Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study

Background. CD4 count at start of combination antiretroviral therapy (ART) is strongly associated with short-term survival, but its association with longer-term survival is less well characterized. Methods. We estimated mortality rates (MRs) by time since start of ART (<0.5, 0.5–0.9, 1–2.9, 3–4.9...

Descripción completa

Detalles Bibliográficos
Autores principales: May, Margaret T., Vehreschild, Jorg-Janne, Trickey, Adam, Obel, Niels, Reiss, Peter, Bonnet, Fabrice, Mary-Krause, Murielle, Samji, Hasina, Cavassini, Matthias, Gill, Michael John, Shepherd, Leah C., Crane, Heidi M., d'Arminio Monforte, Antonella, Burkholder, Greer A., Johnson, Margaret M., Sobrino-Vegas, Paz, Domingo, Pere, Zangerle, Robert, Justice, Amy C., Sterling, Timothy R., Miró, José M., Sterne, Jonathan A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885653/
https://www.ncbi.nlm.nih.gov/pubmed/27025828
http://dx.doi.org/10.1093/cid/ciw183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885653/
https://www.ncbi.nlm.nih.gov/pubmed/27025828
http://dx.doi.org/10.1093/cid/ciw183

Ejemplares similares